<div id="readability-page-1">07:44 AM EDT, 05/15/2026 (MT Newswires) -- Alumis ( ALMS ) reported a Q1 net loss late Thursday of $93.1 million, narrowing from a loss of $99 million a year earlier.Analysts polled by FactSet expected a loss of $93.6 million.Revenue for the quarter ended March 31 was $1.7 million, down from $17.4 million a year earlier.Analysts surveyed by FactSet expected $2.1 million.The company had cash, cash equivalents and marketable securities of $569.5 million as of March 31.Alumis ( ALMS ) continues to expect its existing cash, cash equivalents and marketable securities to fund operating expenses and capital expenditure requirements into Q4 2027, it said.The company's shares were down 2% in premarket activity Friday. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

ALMS

LABU

ARKG

SBIO

Alumis (ALMS) reported a Q1 net loss of $93.1 million, an improvement from a $99 million loss a year prior. Revenue fell to $1.7 million from $17.4 million, below the expected $2.1 million. The company holds $569.5 million in cash and expects to fund operations through Q4 2027. Shares dropped 2% in premarket trading.

Fidelity

Alumis

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

Factset Research

Alumis Q1 Loss Narrows, Revenue Falls; Shares Down Pre-Bell